Articles tagged with Cancer Patients
A novel nanoscale protein measurement technology, NIA, can be used in clinical trials to learn how drugs work and tailor therapy for each patient. The test distinguishes tumor cells from normal cells using protein profiles in the RAS and MAP kinase pathways.
Researchers have found a gene associated with aggressive skin cancer, INPP5A, which could predict its onset and track its progression. The study suggests that targeting this gene may provide new ways to prevent and treat cutaneous squamous cell carcinoma.
Researchers found that African-American patients with non-small cell lung cancer have similar rates of EGFR mutations, making targeted therapies like erlotinib a viable option. This discovery challenges previous assumptions about racial disparities in lung cancer treatment.
Research published in Annals of Oncology suggests that intrauterine devices releasing progestin hormone levonorgestrel combined with GnRH injections can halt and reverse cancer growth in women aged 40 or younger. The treatment has shown promise in treating specific types of endometrial cancer, preserving fertility for young women.
Scientists at the University of Leicester are pioneering the use of turmeric extract to target chemo-resistant cancer cells. The research aims to improve chemotherapy effectiveness and prevent disease recurrence.
Researchers found that circulating tumor cells (CTCs) can provide real-time information on patient's current disease state through biomarker assessments. The technology has potential for non-invasive detection and analysis of cancer biomarkers.
A recent clinical study has shown that patient-specific vaccines can sometimes induce durable complete regression of progressing soft-tissue melanoma metastases. The vaccine was found to be effective in one particular patient who remained in complete remission for over two years, more than four years after her initial diagnosis.
Researchers found that surgery provides high survival rates of 92% for patients with aggressive prostate cancer, outperforming radiation therapy alone in terms of cancer-specific and overall survival. The study suggests that limiting hormone therapy may avoid adverse health consequences for these patients.
A new analysis reveals that male partners of women with breast cancer are at a significantly higher risk of developing severe mood disorders requiring hospitalization. The study found a 39% increased risk of being hospitalized with an affective disorder among men whose partners had breast cancer, compared to those without.
A new study published in the Journal of the National Cancer Institute found that breast cancer survivors with physical limitations are more likely to die from other diseases due to poorer health. Regular physical activity can reduce the risk of breast cancer recurrence and improve survival rates.
This special issue examines the ways cancer treatment affects cardiovascular function and overall survival, highlighting key challenges and potential strategies for minimizing collateral damage. Key findings include the need for cardiac outcomes data and evidence-based practice guidelines to mitigate heart-related complications.
Cells rapidly repair and maintain their structure when exposed to stress, thanks to a newly discovered protein called zyxin. This protein plays a crucial role in maintaining the cell's internal framework, or cytoskeleton, which is essential for cell function.
The American College of Physicians has announced that current stool DNA tests are not effective or cost-effective for colorectal cancer screening. Additionally, researchers have found that using proton pump inhibitors and clopidogrel together does not increase risk for adverse cardiovascular outcomes after a first heart attack. In anot...
Scientists at Huntsman Cancer Institute link loss of Apc to DNA demethylase, a system that erases DNA methylation. This system stalls normal intestinal cell development, leading to stem cell-like cells. Inhibition of the demethylase restores normal development and provides new opportunities for colon cancer treatment.
A study by Dana-Farber Cancer Institute found that cancer patients who die in hospitals or ICUs have worse quality of life, compared to those dying at home with hospice services. Caregivers of patients who died in ICUs are also at higher risk for developing PTSD and prolonged grief disorder.
Women with secondary breast cancer face inadequate support due to lack of knowledge, experience and staff numbers among healthcare professionals. Better training, resources, and services are needed to address this complex condition.
A novel JAK inhibitor has shown significant and lasting benefits for patients with myelofibrosis, a debilitating bone marrow disorder. The treatment produces substantial reductions in enlarged spleens, pain, fatigue, and improved quality of life.
This special edition of The Hastings Center Report examines the promise and pitfalls of personalized medicine, from direct-to-consumer genetic testing to hospice care. Key findings include the need for thousands of human biospecimens for genetic studies, as well as debates over individual mandates in healthcare reform.
A new risk prediction model for venous thromboembolism (VTE) in cancer patients has been developed, incorporating two new biomarkers. The model improves the classification of patients into different risk categories, with a significant increase in accurate predictions of VTE development.
Ipilimumab shows significant survival benefits in stage IV melanoma patients, with a median survival of 10 months. The FDA grants priority review status to this cancer treatment, providing new hope for those with devastating disease.
The University of Louisville has received a $1.5 million NIH grant to develop an interdisciplinary oncology palliative care education program. The program will integrate the services of physicians, nurses, chaplains, and social workers to provide comprehensive care to cancer patients.
Researchers at Dana-Farber Cancer Institute found that multivitamin use did not impact colon cancer outcomes in patients with stage III colon cancer. Multivitamin use had no beneficial effect on patients' survival rates but may have a small association with survival benefits for younger patients and those who are obese.
A pilot study suggests psilocybin, a hallucinogen, is safe and effective in improving mood and reducing anxiety in patients with advanced-stage cancer. The treatment resulted in improved anxiety scores and a depression inventory revealed an improvement of mood that began two weeks after treatment.
A team of researchers discovered HMGB1 as a critical pro-autophagic protein that enhances cell survival and limits programmed cell death. This finding suggests blocking HMGB1 could benefit cancer patients by preventing tumor cells from revving up autophagy to withstand chemotherapy, immunotherapy, and radiation treatment
A recent study found that Mexican-origin women are more likely to be diagnosed with breast cancer at younger ages and have higher mortality rates than non-Hispanic white women. The research highlights the need for tailored prevention and education strategies to address these disparities.
Researchers at TGen have identified two potential anti-cancer drug targets, STK10 and TNK2, for Ewing's sarcoma in children. These kinases play a crucial role in the growth and survival of cancer cells, making them promising therapeutic targets.
A new targeted therapy called PLX4032 has been linked to an 80% response rate in treating advanced melanoma. The treatment, which targets the BRAF protein, has shown significant tumor shrinkage and improved quality of life for some patients.
A new analysis found that rectal cancer rates are rising among young people under 40, with a 3.8% annual increase between 1984 and 2005. The study suggests that endoscopic evaluation should be considered for individuals presenting with rectal bleeding or other signs of the disease.
A new study has demonstrated that combining a specific drug with radiotherapy significantly improves treatment outcomes for cervical cancer patients. The research found that the addition of cisplatin to radiotherapy reduces the likelihood of death by 23%, leading to improved survival rates.
A phase 3 trial found trastuzumab improves median survival to 13.8 months for HER2-positive advanced gastric cancer patients, with a 26% reduction in death rate compared to chemotherapy alone. The treatment's cost effectiveness is questioned due to its estimated £13,857 per patient cost and $55,000 cost per life-year gained.
Chronic health conditions are widespread among stem cell transplant survivors, with 66% reporting at least one condition and 35% experiencing three or more. Chronic graft-versus-host disease also increases the risk of severe or life-threatening conditions.
Palliative care significantly improved the lives of lung cancer patients, extending their survival by an average of 11.6 months compared to those receiving standard care alone. Quality-of-life assessments also showed substantial improvement in the palliative care group.
Researchers at Beth Israel Deaconess Medical Center discovered that the MDM2 oncogene is regulated by a complex signaling pathway involving enzymes CKI and beta-TRCP1. This finding suggests a 'dimmer switch' control mechanism, which could lead to new drug targets for killing tumors.
A recent study published in Blood journal of American Society of Hematology found that cancer cells can contaminate ovarian tissue in women with leukemia, making fertility preservation methods unsafe. The study suggests that cancer cells from acute and chronic leukemias can be present in frozen-thawed ovarian tissue.
A study of over 80,000 patients in the UK found no significant association between oral bisphosphonate use and an increased risk of esophageal or gastric cancer. The analysis excluded patients with less than 6 months follow-up, resulting in 41,826 members in each group.
The UK government's £50 million emergency cancer fund is under fire for its potential to favor patients based on geographical location rather than medical need. The Lancet Editorial argues that this policy undermines the principles of evidence-based medicine and rational healthcare resource allocation.
The Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center has attained NCI designation, recognizing its innovative research and excellent patient care. The center will receive a $7.5 million support grant over five years to advance cancer research and provide patients access to promising new treatments.
A new study found that socioeconomic status predicts survival of Canadian cancer patients, with those from poorer backgrounds facing higher mortality rates. The study also suggests that factors such as cancer biology and access to treatment may play a role in these disparities.
Researchers developed an alphavirus vector to overcome neutralizing antibodies and Tregs, inducing clinically relevant immune responses in patients with metastatic cancer. Repeated administration led to longer overall patient survival, making the approach a promising therapeutic option.
Researchers at Duke University Medical Center developed an experimental vaccine that stimulates an immune response against tumor growth. In a Phase I/II study, the vaccine showed promising results in patients with advanced lung, colon, breast, and pancreatic cancers.
Researchers found that albumin and serum protein parameters are less sensitive than anthropometric measurements for evaluating nutritional status in gastric cancer patients. However, a good correlation was observed between scoring nutritional assessment tools and other general nutritional measurement tools six months after surgery.
A new lab test developed by Japanese scientists can accurately predict imatinib resistance in chronic myeloid leukemia (CML) patients. The test measures protein levels and activity markers to identify resistant cells and determine the next therapeutic option, including dose escalation or combination therapy.
A new study published in The Lancet found that women who underwent radiation therapy as children are more likely to experience stillbirths or baby deaths when attempting to conceive. In contrast, no increased risk was found for men exposed to similar levels of radiation. The authors suggest that uterine damage may be the primary factor...
The GRB7 gene is found to drive an aggressive form of breast cancer and acts independently of the HER-2 gene. Isolating its role could help fine-tune treatment and enable accurate prognoses.
A telephone-based care management program improved cancer patients' pain and depression by 30% and 50%, respectively. The program, which combined telephonic care management with automated symptom monitoring, showed better outcomes for several health-related quality of life domains.
A new prediction tool calculates individualized risk for local recurrence five and ten years after surgery, helping physicians and patients weigh treatment options. The nomogram integrates available information to estimate absolute risk, providing a valuable tool in decision-making.
A new study has found that centralized telephone-based care management can significantly reduce pain and depression in cancer patients. The INCPAD study combined automated calls with follow-up calls from nurse care managers, and the results showed improved outcomes for patients with all types of cancers.
A recent study found that ultra-low-molecular-weight heparin semuloparin reduces the incidence of venous thromboembolism (VTE) and all-cause death by 25% in orthopedic surgery patients compared to enoxaparin.
The European Society for Medical Oncology (ESMO) has published updated clinical practice guidelines for cancer care, providing vital information on diagnosis, treatment plans, and follow-up. The new guidelines cover various tumor types and include expanded sections on cardiotoxicity and fertility considerations.
A new study finds that endoscopic ultrasound (EUS) is associated with improved outcomes in patients with localized pancreatic cancer. EUS evaluation was found to improve overall survival, possibly due to earlier cancer detection and more selective surgery. The study analyzed a large population-based cancer registry and demonstrated the...
Researchers have found a potential link between autoimmune disease scleroderma and cancer in certain patients. The study suggests that patients with specific immune markers are more likely to develop both conditions simultaneously.
Researchers found that black patients are more likely to be diagnosed with advanced cancer and receive inadequate treatment. The study attributes these disparities to patient trust issues, lack of access to quality care, and limited resources at hospitals serving primarily black patients.
The Arizona Myeloma Network recognized Dr. Jeffrey Trent, President of the Translational Genomics Research Institute (TGen), for his organization's support of cancer patients and events such as the 'All Cancers' run. This recognition acknowledges TGen's involvement in patient-advocacy organizations like AzMN.
The Damon Runyon Cancer Research Foundation and Doris Duke Charitable Foundation have partnered to support Tobias J.E. Carling, a young physician-scientist with a $486,000 grant. The foundation aims to address the shortage of talented physician-scientists dedicated to translating research into breakthrough treatments.
Researchers have developed a novel assay to test for multiple tumor markers in bladder cancer using custom-designed MLPA with multiple short synthetic probes. The study found paired tumor and urine samples showed identical marker patterns, suggesting this assay may be used for non-invasive diagnosis.
A comprehensive genomic analysis of prostate cancer has identified key alterations in the androgen receptor pathway and defined subsets of low- and high-risk disease. The study provides valuable resources for cancer research and may lead to the creation of a genetic-based test to determine which tumors require aggressive treatment.
African-American women have more advanced breast cancer at diagnosis and poorer survival outcomes compared to non-Hispanic whites. Despite similar surgical care and adjuvant therapy, African-Americans experience lower overall and breast cancer-specific survival rates due to socio-demographic factors.
A new study suggests that targeted surveillance colonoscopy is cost-effective and effective in reducing colorectal cancer burden. The study recommends a 3/10 strategy of colonoscopy every three years for high-risk patients, which is more effective than no surveillance but slightly more costly.
Research suggests that biologics-naïve Juvenile Idiopathic Arthritis (JIA) patients may have an elevated risk of cancer compared to the general population. The Swedish study found a higher incidence of cancers among paediatric JIA patients identified during the last 40 years.
RG7204, a BRAF inhibitor, has shown significant preclinical activity against melanoma by inhibiting proliferation of tumor cell lines and inducing partial or complete tumor regression. The compound also improved survival rates without associated toxicity in preclinical models.